Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Symptom Management in African-American Men With Localized Prostate Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by National Cancer Institute (NCI).
Recruitment status was  Recruiting
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: October 4, 2008
Last updated: July 14, 2009
Last verified: July 2009

RATIONALE: Gathering information about symptom management from patients with localized prostate cancer may help doctors improve patients' quality of life.

PURPOSE: This clinical trial is studying symptom management in African-American men with localized prostate cancer.

Condition Intervention
Prostate Cancer
Psychosocial Effects of Cancer and Its Treatment
Other: questionnaire administration
Other: survey administration
Procedure: psychosocial assessment and care

Study Type: Interventional
Study Design: Primary Purpose: Health Services Research

Resource links provided by NLM:

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Symptom management taxonomy

Estimated Enrollment: 30
Study Start Date: May 2008
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Detailed Description:


  • Develop a symptom management intervention for African-American men treated for localized prostate cancer, with a particular emphasis on low health literacy men.

OUTLINE: Participants are interviewed by the principal investigator over the phone or meet the principal investigator at the Veterans Administration prostate cancer clinic. If the interview is conducted in the clinic, it is held in a private room in the clinic.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No


  • Biopsy-proven localized prostate cancer

    • Has received treatment for prostate cancer
  • Patient self-identifies as being of African-American descent


  • Able to speak and read in English
  • Has an address in order to receive study materials by mail (a street address or post office box)
  • Has either a telephone in order to be interviewed OR is able to meet the principal investigator at the Veterans Administration prostate clinic and be interviewed there


  • See Disease Characteristics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00767845

United States, Texas
Dan L. Duncan Cancer Center at Baylor College of Medicine Recruiting
Houston, Texas, United States, 77030
Contact: David M. Latini, PhD    877-794-7852   
Sponsors and Collaborators
Baylor College of Medicine
Principal Investigator: David M. Latini, PhD Baylor College of Medicine
  More Information Identifier: NCT00767845     History of Changes
Other Study ID Numbers: CDR0000600455  BCM-H-19323 
Study First Received: October 4, 2008
Last Updated: July 14, 2009
Health Authority: Unspecified

Keywords provided by National Cancer Institute (NCI):
psychosocial effects of cancer and its treatment
stage I prostate cancer
stage II prostate cancer
stage III prostate cancer

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Genital Diseases, Male
Prostatic Diseases processed this record on October 28, 2016